Citius Pharmaceuticals Inc. (CTXR) and Intec Pharma Ltd. (NASDAQ:NTEC) Comparison side by side

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) and Intec Pharma Ltd. (NASDAQ:NTEC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Earnings Valuation

Table 1 demonstrates Citius Pharmaceuticals Inc. and Intec Pharma Ltd.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 hightlights the return on equity, net margins and return on assets of the two companies.

Institutional Insider Ownership

Citius Pharmaceuticals Inc. and Intec Pharma Ltd. has shares owned by institutional investors as follows: 4.2% and 40.23%. 42.8% are Citius Pharmaceuticals Inc.’s share owned by insiders. Comparatively, Intec Pharma Ltd. has 16.08% of it’s share owned by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

For the past year Citius

... read more at: https://stocksbeat.com/2019/06/11/trending-stock-news/citius-pharmaceuticals-inc-ctxr-and-intec-pharma-ltd-nasdaqntec-comparison-side-by-side/

Leave a Reply